Remission of metastatic cervical adenocarcinoma with weekly paclitaxel

We report the use of paclitaxel in the successful treatment of a patient wi th recurrent adenocarcinoma of the cervix. Paclitaxel, 70 mg/m(2) by 1-h in fusion weekly, was administered to a 59-year-old patient with cervical aden ocarcinoma showing lung metastasis. She showed partial clinical response af ter seven cycles, and at the completion of 20 cycles she showed complete re sponse, which was confirmed by chest X-ray and computed tomography scan. To xicities including neurotoxicity were mild. She showed an objective respons e to treatment for over 8 months, and she enjoyed a favorable quality of li fe during and after treatment. Weekly paclitaxel was very well tolerated, y et was effective for recurrent cervical adenocarcinoma.